# Phathom (PHAT) — Overview

PHAT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/phat

## Price

Last close $7.50 on Oct 15, 2026. 52-week range $6.70 – $18.08.

## Company profile

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $239.7M |
| Revenue (quarter) | $74.3M |
| Revenue growth (year over year) | 88.02% |
| Gross profit (trailing twelve months) | $198.7M |
| Gross margin | 82.92% |
| Net income (trailing twelve months) | −$99.1M |
| Net income (quarter) | −$17.6M |
| Net income growth (year over year) | 76.81% |
| Net margin | -41.34% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$1.25 |
| Book value per share | −$4.30 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 205.26% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Phathom (PHAT) profitable?

No. Phathom reported a net loss of $99.1M over the trailing twelve months.

### How much revenue does Phathom (PHAT) make?

Phathom generated $239.7M in revenue over the trailing twelve months, up 88.02% year over year.

### How do I buy stock in Phathom (PHAT)?

PHAT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).